Docosahexaenoic acid in the treatment of idiopathic male infertility


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim: docosahexaenoic acid is one of the most common fatty acids in the cell membranes of sperm. This substance is a structural component of cell membranes, and is responsible for such properties as plasticity and fluidity which are necessary for the implementation of the process of capacitation and acrosome reaction. In addition, docosahexaenoic acid has antioxidant properties. Aim of our study was to assess the effect of dietary supplement docosahexaenoic acid (Brudi PLUS) on such markers of male fertility as the sperm DNA integrity, standard indicators of semen analysis and cryotolerance in infertile men. Materials and methods: a randomized, multicenter, double-blind, placebo-controlled study was conducted. A total of 109 infertile men were recruited to participate in the study. All patients underwent different analyzes, including semen analysis, sperm DNA fragmentation, MAR-test, test ofcryotolerance and electron microscopy analysis ofspermatozoa. In active treatment group patients were prescribed to drug containing 350 mg of docosahexaenoic acid 3 times a day for 90 days. In the control group, patients were administered to a placebo with a similar scheme. All analyzes were repeatedly performed after 3-months of therapy. Results: An increase in the progressive mobility and sperm viability was determined after the test of cryotolerance in the active treatment group. According to electron microscopy analysis of spermatozoa, positive changes were observed in the number ofheads of the normal form with the normal structure of chromatin and acrosome, as well as a decrease in the number of spermatozoa with insufficiently condensed chromatin. Conclusions: the therapy with drug Brudi PLUS in patients with male infertility allows to increase in cryotolerance of sperms as well as decrease in number of sperm ultrastructure defects.

Full Text

Restricted Access

About the authors

I. V Vinogradov

Peoples' Friendship University of Russia

Email: ivvinogradov@mail.ru
andrologist, MD, professor at the Department of Urology and Operative Nephrology

S. I Gamidov

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Email: safargamidov@yandex.ru
andrologist, MD, professor at the Department of Obstetrics, Gynecology, Perinatology and Reproductology

M. Yu Gabliya

Peoples' Friendship University of Russia

Email: mihjyr@mail.ru
andrologist, Ph.D., assistant professor at the Department of Urology and Operative Nephrology

O. B Zhukov

N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology

Email: ob.zhukov@yandex.ru
andrologist

R. I Ovchinnikov

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov

Email: r_ovchinnikov@oparina4.ru
andrologist, Ph.D., Head of Clinical work of the Department of Andrology

O. Yu Malinina

Scientific Research Institute of Medical Rehabilitation and Balneology

Email: malininao@mail.ru
andrologist, Ph.D., senior researcher

A. Yu Popova

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Email: alina-dock@yandex.ru
andrologist, Ph.D., senior researcher, Department of Obstetrics, Gynecology, Perinatology and Reproductology

M. E Chalyi

M.V. Lomonosov Moscow State University

Email: chalyy@bk.ru
andrologist, MD, professor at the Department of Urology and Andrology

E. E Bragina

Scientific Research Institute of A.N. Belozersky Institute of Physico-Chemical Biology of M.V. Lomonosov Moscow State University

Email: bragor@mail.ru
MD, professor, central laboratory of Scientific Research Institute of A.N. Belozersky Institute of Physico-Chemical Biology

A. R Zhivulko

Peoples' Friendship University of Russia

Email: a.zhivulko@yandex.ru
urologist, Ph.D. student at the Department of Urology and Operative Nephrology

References

  1. WHO Manual for the Standardised Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press. 2000.
  2. Овсянникова Т.В. Бесплодный брак. Планирование семьи. 1995;1:24-27
  3. Никифоров О.А., Ломейко Е.А., Ломака С.В., Лавыш И.А. Мужское бесплодие: актуальные вопросы физиологии, этиопатогенеза и диагностики нарушений репродуктивной системы у мужчин. Запорожский медицинский журнал. 2014;4:85
  4. Каприн А.Д., Костин А.А., Кульченко Н.Г., Алиев А.Р. Возможности лучевых методов исследования в диагностике идиопатического мужского бесплодия. Клинический опыт «Двадцатки». 2013;3:7-14
  5. Кульченко Н.Г. Влияние оксидативного стресса на репродуктивное здоровье мужчин. Медицинский вестник Северного Кавказа. 2016;4:12-18
  6. Виноградов И.В., Виноградова Л.М., Базанов П.А., Юткин Е.В. Лечение мужского бесплодия, обусловленного высокой степенью фрагментации ДНК сперматозоидов. Проблемы репродуктологии. 2014;3:67-72
  7. Agarwal A., Roychoudhury S., Bjugstad K.B., Cho C.L. Oxidation-reduction potential of semen: what is its role in the treatment of male infertility? Therapeutic Advances in Urology. 2016;8(5):302-318.
  8. Menezo Y.J., Hazout A., Panteix G., Robert F., Rollet J., Cohen-Bacrie P., Chapuis F., Clement P., Benkhalifa M. Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. Reproductive BioMedicine Online. 2007;14(4):418-421.
  9. Gual-Frau J., Abad C., Amengual M.J., Hannaoui N., Checa M.A., Ribas-Maynou J., Lozano I., Nikolaou A., Benet J., Garci'a-Peiro A., Prats J. Oral antioxidant treatment partly improves integrity of human sperm DNA in infertile grade I. varicocele patients. Hum Fertil. 2015;18(3): 225-229.
  10. Haghighian H.K., Haidari F., Mohammadi-Asl J., Dadfar M. Randomized, triple-blind, placebo-controlled clinical trial examining the effects of alpha-lipoic acid supplement on the spermatogram and seminal oxidative stress in infertile men. Fertil Steril. 2015;104(2):318-324.
  11. Thakur A.S., Littarru G.P., Funahashi I., Painkara U.S., Dange N.S., Chauhan PEffect of Ubiquinol Therapy on Sperm Parameters and Serum Testosterone Levels in Oligoasthenozoospermic Infertile Men. J. Clin Diagn Res. 2015;9(9):BC01-3.
  12. Гамидов С.И., Овчинников Р.И., Попова А.Ю., Авакян А.Ю., Сухих Г.Т. Адъювантная антиоксидантная терапия у больных бесплодием при варикоцеле. Урология. 2017;2(suppl.):64-72
  13. Esmaeili V., Shahverdi A.H., Moghadasian M.H., Alizadeh A.R. Dietary fatty acids affect semen quality: a review. Andrology. 2015;3(3):450-461.
  14. Magtanong L., Ko P., Dixon J. Emerging roles for lipids in non-apoptotic cell death. Cell Death Differ. 2016;23(7):1099-1109.
  15. Murphy E.M., Stanton C., Brien C.O., Murphy C., Holden S., Murphy R.P., Varley P., Boland M.P., Fair S. The effect of dietary supplementation of algae rich in docosahexaenoic acid on boar fertility. Theriogenology. 2017;1(90):78-87.
  16. Sanhueza Catalan J., Duran Agüero S., Torres Garcia J. The fatty acids and relationship with health. Nutr Hosp. 2015;1;32(3):1362-1375.
  17. Calder P.C. Functional Roles of Fatty Acids and Their Effects on Human Health. JPEN J. Parenter Enteral Nutr. 2015:39(1 Suppl):18S-32S.
  18. Holowka D., Baird B. Roles for lipid heterogeneity in immunoreceptor signaling. Biochim Biophys Acta. 2016;1861(8 Pt B):830-836.
  19. Rodri'guez-Cruz M., Serna D.S. Nutrigenomics of rn-3 fatty acids: Regulators of the master transcription factors. Nutrition. 2017;41:90-96.
  20. Eslamian G., Amirjannati N., Rashidkhani B., Sadeghi M.R., Baghestani A.R., Hekmatdoost A. Dietary fatty acid intakes and asthenozoospermia: a case-control study. Fertil Steril. 2015;103(1):190-198.
  21. Aksoy Y., Aksoy H., Altinkaynak K., Aydin H.R., Ozkan A. Sperm fatty acid composition in subfertile men. Prostaglandins Leukot Essent Fatty Acids. 2006;75(2):75-79.
  22. Marti'nez-Soto J.C., Landeras J., Gadea J. Spermatozoa and seminal plasma fatty acids as predictors of cryopreservation success. Andrology. 2013;1(3):365-375.
  23. Lenzi A., Picardo M., Gandini L., Dondero F. Lipids of the sperm plasma membrane: from polyunsaturated fatty acids considered as markers of sperm function to possible scavenger therapy. Hum Reprod Update. 1996;2:246e56.
  24. Kliesch S. Androprotect and prospects for fertility treatment. Urologe A. 2016;55(7):898-903.
  25. Gassei K., Orwig K.E. Experimental methods to preserve male fertility and treat male factor infertility. Fertil Steril. 2016;105(2):256-266.
  26. Vireque A.A., Tata A., Silva O.F., LoTurco E.G., Azzolini A., Ferreira C.R. Effects ofn-6 and n-3 polyunsaturated acid-rich soybean phosphatidylcholine on membrane lipid profile and cryotolerance of human sperm. Fertil Steril. 2016;106(2):273-283.
  27. Masoudi R., Sharafi M., Zare Shahneh A., Towhidi A., Kohram H., Zhandi M., Esmaeili V., Shahverdi A. Effect of dietary fish oil supplementation on ram semen freeze ability and fertility using soybean lecithin- and egg yolk-based extenders. Theriogenology. 2016;1;86(6):1583-1588.
  28. Moallem U., Neta N., Zeron Y., Zachut M., Roth Z. Dietary a-linolenic acid from flaxseed oil or eicosapentaenoic and docosahexaenoic acids from fish oil differentially alter fatty acid composition and characteristics of fresh and frozen-thawed bull semen. Theriogenology. 2015;15;83(7):1110-1120.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies